These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 26509655)

  • 1. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.
    Fan L; Owusu-Edusei K; Schillie SF; Murphy TV
    Hepatology; 2016 May; 63(5):1471-80. PubMed ID: 26509655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load.
    Fan L; Owusu-Edusei K; Schillie SF; Murphy TV
    Obstet Gynecol; 2014 May; 123(5):929-937. PubMed ID: 24785842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal hepatitis B prevention program in Shandong Province, China. Evaluation and progress.
    Zhang L; Ko S; Lv J; Ji F; Yan B; Xu F; Xu A
    Hum Vaccin Immunother; 2014; 10(9):2755-60. PubMed ID: 25483482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():768-71. PubMed ID: 23013723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study.
    Nayagam S; de Villiers MJ; Shimakawa Y; Lemoine M; Thursz MR; Walsh N; Hallett TB
    Lancet Gastroenterol Hepatol; 2023 Jul; 8(7):635-645. PubMed ID: 37150181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus: A prospective cohort study.
    Wei KP; Zhu FC; Liu JX; Yan L; Lu Y; Zhai XJ; Chang ZJ; Zeng Y; Li J; Zhuang H
    Vaccine; 2018 Jan; 36(2):256-263. PubMed ID: 29195717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenofovir prophylaxis for preventing mother-to-child hepatitis B virus transmission in China: A cost-effectiveness analysis.
    Yin J; Liang P; Chen G; Wang F; Cui F; Liang X; Zhuang G
    Int J Infect Dis; 2020 Jun; 95():118-124. PubMed ID: 32205288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of the national Perinatal Hepatitis B Prevention Program.
    Barbosa C; Smith EA; Hoerger TJ; Fenlon N; Schillie SF; Bradley C; Murphy TV
    Pediatrics; 2014 Feb; 133(2):243-53. PubMed ID: 24394684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.
    ; Dionne-Odom J; Tita AT; Silverman NS
    Am J Obstet Gynecol; 2016 Jan; 214(1):6-14. PubMed ID: 26454123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Hepatitis B Birth-Dose Vaccination in São Tomé and Príncipe: A Program Assessment and Cost-Effectiveness Study.
    Hagan JE; Carvalho E; Souza V; Queresma Dos Anjos M; Abimbola TO; Pallas SW; Tevi Benissan MC; Shendale S; Hennessey K; Patel MK
    Am J Trop Med Hyg; 2019 Oct; 101(4):891-898. PubMed ID: 31392947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
    Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
    Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
    Yin YZ; Zhou J; Zhang PZ; Hou HY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B Surface Antigen Screening Among Pregnant Women and Care of Infants of Hepatitis B Surface Antigen-Positive Mothers - Guam, 2014.
    Abara WE; Cha S; Malik T; DeSimone MS; Schumann B; Mallada E; Klemme M; Aguon V; Santos AM; Collier M; Kamb M
    MMWR Morb Mortal Wkly Rep; 2017 May; 66(19):506-508. PubMed ID: 28520708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.
    Cui F; Luo H; Wang F; Zheng H; Gong X; Chen Y; Wu Z; Miao N; Kane M; Hennessey K; Hadler SC; Hutin YJ; Liang X; Yang W
    Vaccine; 2013 Dec; 31 Suppl 9():J36-42. PubMed ID: 24331019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand.
    Janekrongtham C; Punsuwan N; Thitichai P; Lertpiriyasuwat C; Pan-Ngum W; Poovorawan K; Jantarapakde J; Tangkijvanich P
    BMJ Open; 2023 Jul; 13(7):e067275. PubMed ID: 37474179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited benefit of hepatitis B immunoglobulin prophylaxis in children of hepatitis B e antigen-negative mothers.
    Lee LY; Aw MM; Saw S; Rauff M; Tong PY; Lee GH
    Singapore Med J; 2016 Oct; 57(10):566-569. PubMed ID: 26778725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis.
    Tamandjou Tchuem CR; Andersson MI; Wiysonge CS; Mufenda J; Preiser W; Cleary S
    Vaccine; 2021 May; 39(23):3141-3151. PubMed ID: 33962836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.
    Lu Y; Zhu FC; Liu JX; Zhai XJ; Chang ZJ; Yan L; Wei KP; Zhang X; Zhuang H; Li J
    Vaccine; 2017 Dec; 35(48 Pt B):6627-6633. PubMed ID: 29079104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.